addS

Wednesday 2 April 2014

HIV Therapeutics Market to 2019 - Limited Pipeline Efficacy Improvement, Patent Expirations and Stringent Healthcare Spending to Suppress Market Growth

HIV Therapeutics Market to 2019 - Limited Pipeline Efficacy Improvement, Patent Expirations and Stringent Healthcare Spending to Suppress Market Growth


The leading business intelligence provider GBI Research has released its latest research report, entitled “HIV Therapeutics Market to 2019 – Limited Pipeline Efficacy Improvement, Patent Expirations and Stringent Healthcare Spending to Suppress Market Growth”. The report provides insights into the HIV (Human Immunodeficiency Virus) therapeutics market including market forecasts up to 2019. It provides an in-depth analysis of the major marketed products, as well as insights into the HIV therapeutics R&D pipeline. The report provides in-depth analysis of the unmet needs, drivers and barriers that affect the global HIV therapeutics market. The report analyzes the market for HIV therapeutics in eight major markets of the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain), Japan and Canada. The report discusses the global pipeline for all the HIV molecules across various stages of development. The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts. GBI Research found that the HIV therapeutics market in the top seven markets was valued at $14.3 billion in 2012 and is projected to witness growth of 1.9% during the 2012–2019 forecast period to reach $16.3 billion.


Browse Full Report With TOC: http://www.marketresearchreports.biz/analysis-details/hiv-therapeutics-market-to-2019-limited-pipeline-efficacy-improvement-patent-expirations-and-stringent-healthcare-spending-to-suppress-market-growth


Scope

The report analyzes treatment usage patterns, drug types available and pipeline and market forecasts across indications for HIV.

The report covers and includes:

A brief introduction to HIV, including the symptoms, pathogenesis, risk factors and diagnosis
In-depth analysis of major glucose-lowering drugs for HIV, including analyses of their safety, efficacy, treatment patterns, strengths/weaknesses and overall commercial prospects. Includes a heat map comparing major drugs in terms of safety, efficacy and dosing parameters.
Comprehensive review of the pipeline for HIV therapies, including individual analysis of a number of late-stage pipeline drugs that are likely to enter the market in the forecast period. The pipeline is analyzed on the basis of phase distribution, molecule types and molecular targets.
Additional in-depth analysis of pipeline drug clinical trials by phase, molecule type, trial size, trial duration and program failure rate analyses for each molecule type and mechanism of action
Multi-scenario forecast data for the market up to 2019, taking into account how it will be affected by the introduction of new drugs, the expiry of key patents on current drugs, and changes in disease epidemiology across key developed markets including the US, Japan, Germany, the UK, France, Italy, Spain and Canada
Discussion of the drivers and barriers for market growth

Reasons to Buy

Browse Full Report With TOC: http://www.marketresearchreports.biz/sample/sample/193009

The report will enhance your decision-making capability. It will allow you to:

Align your product portfolio to the markets with high growth potential.
Develop market-entry and market expansion strategies by identifying the potential region and HIV/AIDS therapeutics market segments poised for strong growth.
Create a more tailored country strategy through the understanding of key drivers and barriers of the global HIV/AIDS therapeutics market.
Develop key strategic initiatives by understanding the key focus areas and top selling products of leading companies.
Accelerate and strengthen your market position by identifying key companies for mergers, acquisitions and strategic partnerships.


Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 Disease Introduction
2.2 Route of HIV Transmission
2.3 Etiology
2.4 Classification of HIV-1 Subtypes
2.5 Pathophysiology 12
2.5.1 HIV-1 Replication Cycle
2.5.2 Mechanism of CD4 T-Cell Death
2.5.3 Latent Infection and Viral Persistence
2.6 Symptoms
2.7 Diagnosis
2.7.1 HIV Antibody Assay
2.7.2 Rapid HIV Antibody Test
2.7.3 Western Blot
2.7.4 HIV p24 Antigen Test
2.7.5 Antigen-Antibody Immunoassay
2.7.6 Polymerase Chain Reaction Test
2.7.7 HIV Home-Testing Kit
2.8 Disease Staging
2.8.1 WHO Clinical Staging
2.8.2 Centers for Disease Control and Prevention Classification System
2.8.3 Immunological Classification
2.9 Co-morbidities and Complications
2.10 Epidemiology
2.11 Treatment Options
2.11.1 Nucleoside/Nucleotide Reverse Transcriptase Inhibitor
2.11.2 Non-Nucleoside Reverse Transcriptase Inhibitor
2.11.3 Entry Inhibitor
2.11.4 Integrase Inhibitor
2.11.5 HIV-1 Protease Inhibitor
2.11.6 Pharmacokinetic Enhancer
2.12 Treatment Algorithm


To Get Download Full Report with TOC:  http://www.marketresearchreports.biz/analysis/193009


3 Marketed Products
3.1 Therapeutic Landscape
3.1.1 Multi-class Combinations
3.1.2 Nucleotide Reverse Transcriptase Inhibitors
3.1.3 Non-Nucleoside Reverse Transcriptase Inhibitor
3.1.4 HIV Protease Inhibitor
3.1.5 Integrase Inhibitor
3.1.6 Entry Inhibitor
3.2 Comparative Efficacy and Safety
3.2.1 Multi-class Combination
3.2.2 Nucleotide Reverse Transcriptase Inhibitor
3.2.3 Non-Nucleotide Reverse Transcriptase Inhibitor
3.2.4 HIV Protease Inhibitor
3.2.5 Integrase Inhibitor
3.2.6 Entry Inhibitor
3.3 Unmet Need

4 Pipeline for HIV
4.1 Overall Pipeline
4.2 Mechanism of Action in HIV Pipeline
4.3 Clinical Trials
4.3.1 Failure Rate of Developmental Pipeline
4.3.2 Clinical Trial Sizes
4.3.3 Clinical Trial Duration
4.3.4 Summary of Clinical Trial and Risk Analysis
4.4 Promising Candidates in Pipeline
4.4.1 572-Trii (dolutegravir + abacavir sulfate + lamivudine) – Shionogi-ViiV Healthcare
4.4.2 Atazanavir sulfate + cobicistat – Bristol-Myers Squibb, Gilead
4.4.3 Elvitegravir + cobicistat + emtricitabine + tenofovir alafenamide – Gilead
4.4.4 Apricitabine – Avexa
4.4.5 Remune (IR-103) – Immune Response BioPharma
4.4.6 Censavudine – Bristol-Myers Squibb
4.4.7 Elvucitabine – Achillion
4.4.8 Cenicriviroc – Tobira Therapeutics
4.5 Heat Map and Competitor Matrix for HIV Pipeline Products

5 Market Forecast to 2019
5.1 Geographical Markets
5.1.1 Global Market
5.1.2 North America
5.1.3 Top Five Countries in Europe
5.1.4 Japan
5.2 Drivers and Barriers
5.2.1 Drivers
5.2.2 Barriers

6 Deals and Strategic Consolidations
6.1 Major Co-development Deals
6.1.1 DFH Pharma Enters Agreement with Hetero Drugs
6.1.2 GlaxoSmithKline Enters Agreement with Concert Pharmaceuticals
6.1.3 GenVec Enters Agreement with SAIC-Frederick
6.2 Major Licensing Deals
6.2.1 Merck Enters Agreement with Chimerix
6.2.2 Bristol-Myers Squibb Enters Agreement with Gilead
6.2.3 Japan Tobacco Enters Agreement with Gilead
6.2.4 Gilead Enters Agreement with Tibotec
6.2.5 Benitec Enters Agreement with Calimmune
6.2.6 Bristol-Myers Squibb Enters Agreement with Oncolys BioPharma

7 Appendix 1

Latest Report:

Gastric Cancer Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019 : http://www.marketresearchreports.biz/analysis-details/gastric-cancer-drugs-market-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019

Gastric cancer refers to the cancer arising from lining of stomach. It may lead to uncontrolled growth of malignant cells that originate in stomach tissue and forms a tumor in any part of the stomach. Mainly there are five types of gastric cancer namely adenocarcinoma, squamous cell cancer, lymphoma, gastrointestinal stromal tumors, neuroendocrine tumors. From all these types, adenocarcinoma types of cancer originates from the innermost lining of stomach and accounts for more than 90% of all gastric tumors. Dysphagia, frequent burping, heartburn, stomachache are some of the early stomach cancer symptoms. The drugs of gastric cancers works on extracellular and intracellular domain of HER2 receptor of stomach and continuously suppress the tumor proliferation that lead to cell stasis and death.

According to World Health Organization, approximately 800,000 cancer related deaths are caused by gastric cancer every year and American Cancer Society estimated that in 2013 approximately 21,600 cases of gastric cancer will be diagnosed. This increasing incidences of gastric cancer drives the market of gastric cancer drugs. In addition, introduction of new therapies like Taxotere, Xeloda and Herceptin are also expected to propel the demand for gastric cancer drugs. However, less number of commercially available drugs for the treatment of gastric cancer may hinder the market growth.

The global Gastric Cancer Drugmarket is categorized based on the following:

By Class of Drugs

    Doxorubicin Hydrochloride
    Fluorouracil
    Trastuzumab
    Mitomycin C
    Docetaxel
    Imatinib
    Sunitinib

Geographically, China and Japan dominate the global gastric cancer drug market due to large patient base and rise in treatment seeking population in these regions.Also, with the rise in geriatric population the number of people diagnosed with gastric cancer also increases which ultimately impacts the growth of gastric cancer drugs in these markets. The market of gastric cancer drug in North America and Europeholds a strong growth as the key players are domiciled in these regions. With the rise in uptake of gastric cancer drugs namely is Herceptin, Erbitux and Afitnitor also accentuates the growth of these drugs in the North American and European market.However, the total number of newly diagnosed patients are five times greater in China and Japan than the United States, making Japanese and Chinese market commercially attractive for developers.

Sample Request : http://www.marketresearchreports.biz/sample/toc/192741



Botanical And Plant Derived Drugs Market - Global Industry Analysis, Size, Share, Growth, Trend And Forecast 2013 – 2019: http://www.marketresearchreports.biz/analysis-details/botanical-and-plant-derived-drugs-market-global-industry-analysis-size-share-growth-trend-and-forecast-2013-2019

Botanical drugs are drugs develop through botanical drug and research pathway, whereas plant derived drugs are combination of botanical as well as other approved drugs that contains plant materials, synthetic and semi synthetic substances. These botanical products are intended for use in the mitigation, cure, diagnosis and treatment or prevention of diseases in humans.

The global market for botanical and plant derived drugs is witnessing a significant growth over recent years due to rising usage of these drugs in different parts of the world. Increased focus of research institutes and clinical trial studies, price reduction and improved technological and sociological development are major driving factors for the growth of this market. However, low acceptance of these drugs for the treatment of lethal diseases is a major restraint for the market. On the other hand, rising number of FDA approved botanical drugs and their application is a key opportunity for the market. Some of the major classes of botanical and plant derived drugs are Tarpenes and Steroids, Glycosides, Ergot Alkaloids, Morphine Alkaloids and Vinca Alkaloids.

Global market of botanical and plant derived drugs market is primarily divided into two segments: based on geography and based on therapeutic applications. The U.K., Germany and France are major countries of the European Region. On the basis of therapeutic application, the market is segmented into hormone related disease therapy, infectious diseases, pain and central nervous system disorders, cardiovascular and metabolic diseases, respiratory and oncology diseases treatment. Some of the major players operating in the market are Abott Laboratories, Bayer Healthcare, Bionova, Bristol Myers and Curapharm.

Sample Request : http://www.marketresearchreports.biz/sample/toc/192763


Contact US:  
Office: United States
State Tower
90 State Street, Suite 700
Albany, NY 12207
United States

Toll Free: 866-997-4948
Tel: +1-518-618-1030
E: sales@marketresearchreports.biz


The Global Market For Nanocellulose To 2020

Global Market For Nanocellulose To 2020

Over the last few years the conversion of renewable lignocellulosic biomass and natural biopolymers into chemicals, liquid fuels and feed supplements has received increasing attention. The exploitation of nanostructured cellulose, in the form of nanocrystalline cellulose (NCC), micro/nanofibrillar cellulose (MFC/NFC) and bacterial cellulose (BC) has mainly been motivated by the sustainability trend, ever-increasing prices of petroleum and the high-energy intensity in production of chemicals and synthetic polymers. This growing interest is related to their unsurpassed quintessential physical and chemical properties.

Browse Full Report With TOC: http://www.marketresearchreports.biz/analysis-details/the-global-market-for-nanocellulose-to-2020
 


Today there is a substantial amount of research on these materials, and commercial development is now underway with some very promising applications. With appropriate conversion and extraction technologies as well as modification and characterization, nanocellulose can be integrated into bio-based products. Their use in novel materials and various applications has substantial environmental and economic benefits. Nanocellulose can be produced from several raw materials and applying various pre-treatments, which yield tailor-made nanofibrils with specific morphology and surface chemistry. The material has great potential in applications such as strength enhancers in paper, as additives, in emulsions, as oxygen barriers for food packaging and in biomedical devices.

Nanocellulose is also being developed for use in novel applications ranging from scaffolds in tissue engineering, artificial skin and cartilage, wound healing and vessel substitutes to biodegradable food packaging. Applications in polymer reinforcement and anti-microbial films will be hitting the market soon. FP Innovations estimates the market to be worth $250 million in North America by 2020.

Browse Full Report With TOC: http://www.marketresearchreports.biz/sample/sample/193016


Table of Content

EXECUTIVE SUMMARY

A novel class of renewable and sustainable nanomaterials.

INTRODUCTION

Nanocellulose properties, advantages and applications.

APPLICATIONS

Applications of NanoFibrillar Cellulose (NFC), NanoCrystalline Cellulose (NCC) and Bacterial Cellulose (BC).

PRODUCTION METHODS

Nanocellulose production techniques.

REGULATIONS & STANDARDS

Initiatives and studies in nanocellulose standards, toxicity and regulation.

COMMERCIALIZATION

To Get Download Full Report with TOC: http://www.marketresearchreports.biz/analysis/193016

PRODUCTION VOLUMES

Facilities, producers, production capacities, products and prices.

PATENTS AND PUBLICATIONS

Research papers and patent publications on nanocellulose from 1997-2013.
MARKET SUPPLY CHAIN

Overview of the nanocellulose supply chain including producers, application developers and OEMs.

COMPOSITES

Nanocellulose the composites market, including technology roadmap, applications, market penetration estimates and companies.

PAPER & PULP

Nanocellulose the paper & pulp market, including technology roadmap, applications, market penetration estimates and companies.

BIOMEDICAL

Nanocellulose the biomedical market, including technology roadmap, applications, market penetration estimates and companies.

COATINGS & FILMS

Nanocellulose the coatings & films market, including technology roadmap, applications, market penetration estimates and companies.

RHEOLOGY MODIFIERS

Nanocellulose the rheology modifiers market, including technology roadmap, applications, market penetration estimates and companies.

OTHER APPLICATIONS

Graphene in the sensors, aerogels, oil, filtration and electronics markets.

COMPANIES

Producers, application developers and OEMs.

RESEARCH CENTRES

Latest Report:

Gastric Cancer Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019 : http://www.marketresearchreports.biz/analysis-details/gastric-cancer-drugs-market-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019

Gastric cancer refers to the cancer arising from lining of stomach. It may lead to uncontrolled growth of malignant cells that originate in stomach tissue and forms a tumor in any part of the stomach. Mainly there are five types of gastric cancer namely adenocarcinoma, squamous cell cancer, lymphoma, gastrointestinal stromal tumors, neuroendocrine tumors. From all these types, adenocarcinoma types of cancer originates from the innermost lining of stomach and accounts for more than 90% of all gastric tumors. Dysphagia, frequent burping, heartburn, stomachache are some of the early stomach cancer symptoms. The drugs of gastric cancers works on extracellular and intracellular domain of HER2 receptor of stomach and continuously suppress the tumor proliferation that lead to cell stasis and death.

According to World Health Organization, approximately 800,000 cancer related deaths are caused by gastric cancer every year and American Cancer Society estimated that in 2013 approximately 21,600 cases of gastric cancer will be diagnosed. This increasing incidences of gastric cancer drives the market of gastric cancer drugs. In addition, introduction of new therapies like Taxotere, Xeloda and Herceptin are also expected to propel the demand for gastric cancer drugs. However, less number of commercially available drugs for the treatment of gastric cancer may hinder the market growth.

The global Gastric Cancer Drugmarket is categorized based on the following:

By Class of Drugs

    Doxorubicin Hydrochloride
    Fluorouracil
    Trastuzumab
    Mitomycin C
    Docetaxel
    Imatinib
    Sunitinib

Geographically, China and Japan dominate the global gastric cancer drug market due to large patient base and rise in treatment seeking population in these regions.Also, with the rise in geriatric population the number of people diagnosed with gastric cancer also increases which ultimately impacts the growth of gastric cancer drugs in these markets. The market of gastric cancer drug in North America and Europeholds a strong growth as the key players are domiciled in these regions. With the rise in uptake of gastric cancer drugs namely is Herceptin, Erbitux and Afitnitor also accentuates the growth of these drugs in the North American and European market.However, the total number of newly diagnosed patients are five times greater in China and Japan than the United States, making Japanese and Chinese market commercially attractive for developers.

Sample Request : http://www.marketresearchreports.biz/sample/toc/192741



Botanical And Plant Derived Drugs Market - Global Industry Analysis, Size, Share, Growth, Trend And Forecast 2013 – 2019: http://www.marketresearchreports.biz/analysis-details/botanical-and-plant-derived-drugs-market-global-industry-analysis-size-share-growth-trend-and-forecast-2013-2019

Botanical drugs are drugs develop through botanical drug and research pathway, whereas plant derived drugs are combination of botanical as well as other approved drugs that contains plant materials, synthetic and semi synthetic substances. These botanical products are intended for use in the mitigation, cure, diagnosis and treatment or prevention of diseases in humans.

The global market for botanical and plant derived drugs is witnessing a significant growth over recent years due to rising usage of these drugs in different parts of the world. Increased focus of research institutes and clinical trial studies, price reduction and improved technological and sociological development are major driving factors for the growth of this market. However, low acceptance of these drugs for the treatment of lethal diseases is a major restraint for the market. On the other hand, rising number of FDA approved botanical drugs and their application is a key opportunity for the market. Some of the major classes of botanical and plant derived drugs are Tarpenes and Steroids, Glycosides, Ergot Alkaloids, Morphine Alkaloids and Vinca Alkaloids.

Global market of botanical and plant derived drugs market is primarily divided into two segments: based on geography and based on therapeutic applications. The U.K., Germany and France are major countries of the European Region. On the basis of therapeutic application, the market is segmented into hormone related disease therapy, infectious diseases, pain and central nervous system disorders, cardiovascular and metabolic diseases, respiratory and oncology diseases treatment. Some of the major players operating in the market are Abott Laboratories, Bayer Healthcare, Bionova, Bristol Myers and Curapharm.

Sample Request : http://www.marketresearchreports.biz/sample/toc/192763


Contact US:  
Office: United States
State Tower
90 State Street, Suite 700
Albany, NY 12207
United States

Toll Free: 866-997-4948
Tel: +1-518-618-1030
E: sales@marketresearchreports.biz


Pancreatic Adenocarcinoma Therapeutics Market in Major Developed Markets to 2019 - Early Stage Pipeline Shows Diversity of Novel Targets though Commercial Impact Remains Distant

Pancreatic Adenocarcinoma Therapeutics Market in Major Developed Markets to 2019 - Early Stage Pipeline Shows Diversity of Novel Targets though Commercial Impact Remains Distant

Research, the leading business intelligence provider, has released its latest research: ‘Pancreatic Adenocarcinoma Therapeutics Market in Major Developed Markets to 2019 - Early Stage Pipeline Shows Diversity of Novel Targets though Commercial Impact Remains Distant’, which provides in-depth analysis of pancreatic adenocarcinoma market within the eight major developed markets of the US, UK, France, Germany, Italy, Spain, Japan and Canada. The report provides an estimation of the market size for 2012, along with market forecasts to 2019. It also covers disease epidemiology, treatment algorithms, treatment patterns, in-depth analysis of the pipeline, and deal analysis. The global pancreatic adenocarcinoma therapeutics market is expected to grow from approximately $856m in 2012 to $1.2 billion in 2019, with growth driven by small changes in multiple factors.

Browse Full Report With TOC: http://www.marketresearchreports.biz/analysis-details/pancreatic-adenocarcinoma-therapeutics-market-in-major-developed-markets-to-2019-early-stage-pipeline-shows-diversity-of-novel-targets-though-commercial-impact-remains-distant

These include the impact of the drugs approved in the forecast period, but also the increase in the prevalence of the disease and minor improvements in diagnostics that result in more patients being eligible for pharmacological.

Scope

 A brief introduction to pancreatic adenocarcinoma, including the disease’s pathogenesis, risk factors, diagnosis, staging and treatment algorithms for each stage.

In-depth analysis of drugs available for the treatment of pancreatic adenocarcinoma, including analyses of their safety, efficacy, treatment patterns and strengths/weaknesses. Includes a heat map comparing the drugs in terms of safety and efficacy.

Comprehensive review of the pipeline for pancreatic adenocarcinoma therapies, including individual analysis of a number of late-stage pipeline drugs that are likely to enter the market in the forecast period. The pipeline is analyzed on the basis of phase distribution, molecule types and molecular targets, program type.

Browse Full Report With TOC: http://www.marketresearchreports.biz/sample/sample/193010

Additional in-depth analysis of pipeline drug clinical trials by phase, molecule type, trial size, trial duration and program failure rate analyses for each molecule type and mechanism of action.
Multi-scenario forecast data of the market to 2019, taking into account how it will be affected by the introduction of new drugs, the expiry of key patents on current drugs and the changes in disease epidemiology across the key developed markets including the US, Japan, Germany, the UK, France, Italy and Spain.

Discussion of the drivers and barriers for market growth.

Discussion of the licensing and co-development deals landscape in pancreatic adenocarcinoma, Includes an analysis of licensing deals by stage of development, molecule type and mechanism of action. Also includes an analysis of both licensing and co-development deals by year and value and network maps of licensing and co-development deals.


To Get Download Full Report with TOC: http://www.marketresearchreports.biz/analysis/193010


Reasons to Buy

Understand the vast scope and diversity of the pipeline, including which molecule types and mechanisms of action are prominent.

Observe the trends in clinical trial duration and size amongst clinical Phases, between molecule types and mechanisms of action, and use the clinical trial failure rate analysis to assess the risk profiles of current and/or future developmental programs for pancreatic adenocarcinoma therapeutics.

Assess the potential clinical and commercial impact of current late-stage pipeline molecules on the pancreatic adenocarcinoma therapeutics market.



Latest Report:

Gastric Cancer Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019 : http://www.marketresearchreports.biz/analysis-details/gastric-cancer-drugs-market-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019

Gastric cancer refers to the cancer arising from lining of stomach. It may lead to uncontrolled growth of malignant cells that originate in stomach tissue and forms a tumor in any part of the stomach. Mainly there are five types of gastric cancer namely adenocarcinoma, squamous cell cancer, lymphoma, gastrointestinal stromal tumors, neuroendocrine tumors. From all these types, adenocarcinoma types of cancer originates from the innermost lining of stomach and accounts for more than 90% of all gastric tumors. Dysphagia, frequent burping, heartburn, stomachache are some of the early stomach cancer symptoms. The drugs of gastric cancers works on extracellular and intracellular domain of HER2 receptor of stomach and continuously suppress the tumor proliferation that lead to cell stasis and death.

According to World Health Organization, approximately 800,000 cancer related deaths are caused by gastric cancer every year and American Cancer Society estimated that in 2013 approximately 21,600 cases of gastric cancer will be diagnosed. This increasing incidences of gastric cancer drives the market of gastric cancer drugs. In addition, introduction of new therapies like Taxotere, Xeloda and Herceptin are also expected to propel the demand for gastric cancer drugs. However, less number of commercially available drugs for the treatment of gastric cancer may hinder the market growth.

The global Gastric Cancer Drugmarket is categorized based on the following:

By Class of Drugs

    Doxorubicin Hydrochloride
    Fluorouracil
    Trastuzumab
    Mitomycin C
    Docetaxel
    Imatinib
    Sunitinib

Geographically, China and Japan dominate the global gastric cancer drug market due to large patient base and rise in treatment seeking population in these regions.Also, with the rise in geriatric population the number of people diagnosed with gastric cancer also increases which ultimately impacts the growth of gastric cancer drugs in these markets. The market of gastric cancer drug in North America and Europeholds a strong growth as the key players are domiciled in these regions. With the rise in uptake of gastric cancer drugs namely is Herceptin, Erbitux and Afitnitor also accentuates the growth of these drugs in the North American and European market.However, the total number of newly diagnosed patients are five times greater in China and Japan than the United States, making Japanese and Chinese market commercially attractive for developers.

Sample Request : http://www.marketresearchreports.biz/sample/toc/192741



Botanical And Plant Derived Drugs Market - Global Industry Analysis, Size, Share, Growth, Trend And Forecast 2013 – 2019: http://www.marketresearchreports.biz/analysis-details/botanical-and-plant-derived-drugs-market-global-industry-analysis-size-share-growth-trend-and-forecast-2013-2019

Botanical drugs are drugs develop through botanical drug and research pathway, whereas plant derived drugs are combination of botanical as well as other approved drugs that contains plant materials, synthetic and semi synthetic substances. These botanical products are intended for use in the mitigation, cure, diagnosis and treatment or prevention of diseases in humans.

The global market for botanical and plant derived drugs is witnessing a significant growth over recent years due to rising usage of these drugs in different parts of the world. Increased focus of research institutes and clinical trial studies, price reduction and improved technological and sociological development are major driving factors for the growth of this market. However, low acceptance of these drugs for the treatment of lethal diseases is a major restraint for the market. On the other hand, rising number of FDA approved botanical drugs and their application is a key opportunity for the market. Some of the major classes of botanical and plant derived drugs are Tarpenes and Steroids, Glycosides, Ergot Alkaloids, Morphine Alkaloids and Vinca Alkaloids.

Global market of botanical and plant derived drugs market is primarily divided into two segments: based on geography and based on therapeutic applications. The U.K., Germany and France are major countries of the European Region. On the basis of therapeutic application, the market is segmented into hormone related disease therapy, infectious diseases, pain and central nervous system disorders, cardiovascular and metabolic diseases, respiratory and oncology diseases treatment. Some of the major players operating in the market are Abott Laboratories, Bayer Healthcare, Bionova, Bristol Myers and Curapharm.

Sample Request : http://www.marketresearchreports.biz/sample/toc/192763


Contact US:  
Office: United States
State Tower
90 State Street, Suite 700
Albany, NY 12207
United States

Toll Free: 866-997-4948
Tel: +1-518-618-1030
E: sales@marketresearchreports.biz


Monday 31 March 2014

Naphtha Market (Chemicals, Energy/Fuels And Others) - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019

Naphtha Market (Chemicals, Energy/Fuels And Others) - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019

Generally, there are two main classes of naphtha - heavy naphtha and paraffinic naphtha. Paraffinic naphtha is rich in olefins and is suitable for polyolefin and olefin production.  Heavy naphtha is mainly used for production of aromatics. The report provides a strategic analysis of the global market for naphtha in terms of volume (MM Tons) as well as revenue (USD Million), for the period 2012 to 2019.

The study is segmented by application and by geography in terms of both volume and revenue. The application segment is classified as chemicals (benzene, toluene and xylene, and petrochemicals etc), energy/fuel (power plants/ fertilizer units, steel plant, etc.) and others (non renewable, etc). The geographies covered in this report include North America, Europe, Asia-Pacific and Rest of the World (RoW).

Browse Full Report With TOC:
http://www.marketresearchreports.biz/analysis-details/naphtha-market-global-industry-size-market-share-trends-analysis-and-forecasts-2012-2018

The study identifies the market trends and drivers of the global naphtha market along with risk and opportunities of the industry. The study also provides value chain analysis and Porter’s five forces model which provides an insight into industry competition by defining the power of the buyer and supplier, threat of substitutes and new entrants and the competition in the market.

The study includes competitive landscape including the share of the global naphtha market along with company profiles of major industry participants. Key market participants profiled in this study include British Petroleum, Shell Chemicals, Chevron, ExxonMobil, Indian Oil Corporation, SABIC, Total S.A. and Mitsubishi Chemical. The market players are profiled with aspects such as company overview, financial overview, SWOT analysis, business strategies and recent developments.

Naphtha Market: Application Analysis

Chemicals
Energy/fuel
Others

Browse Full Report With TOC:
http://www.marketresearchreports.biz/sample/sample/138973

Naphtha Market: Regional Analysis

North America
Europe
Asia Pacific
RoW

Table of Content

Chapter 1 Preface
1.1 Report Description
1.2 Market segmentation
1.3 Research Scope
1.3.1 Assumptions
1.4 Research Methodology

Chapter 2 Executive Summary
2.1.1 Global naphtha market, volume and revenue, 2012 – 2019 (MM Tons), (USD Million)

Chapter 3 Naphtha Market – Industry Analysis
3.1 Introduction
3.2 Value chain analysis
3.3 Drivers
3.3.1 Growing end-user industries
3.3.1.1 Global paints & coating and automotive plastic market revenue, 2010 – 2013 (USD Billion)
3.3.2 Development of new manufacturing processes
3.4 Restraints
3.4.1 Volatile crude oil prices
3.4.1.1 Global crude oil prices, estimates and forecast, 2009 – 2012 (USD/barrel)
3.4.2 Shift in trends from naphtha towards cheaper alternatives
3.4.2.1 Global shale gas prices, 2011 – 2013 (USD/MMBtu)
3.5 Opportunities
3.5.1 LPG-naphtha margin gap narrows
3.6 Porter’s five force analysis
3.6.1 Bargaining power of suppliers
3.6.2 Bargaining power of buyers
3.6.3 Threat of new entrants
3.6.4 Threat of substitutes
3.6.5 Degree of competition
3.7 Market Attractiveness
3.8 Company market share
3.8.1 Global Naphtha Market: Company Market Share, 2012

To Get Download Full Report with TOC:
http://www.marketresearchreports.biz/analysis/138973

Chapter 4 Naphtha Market - Application Analysis
4.1 Global naphtha market volume, by application, 2012 & 2019
4.1.1 Global naphtha demand by chemical applications, 2012 – 2019 (MM Tons), (USD Million)
4.1.2 Global naphtha demand by energy/fuel applications, 2012 – 2019 (MM Tons), (USD Million)
4.1.3 Global naphtha demand by other applications, 2012 – 2019 (MM Tons), (USD Million)

Contact US:  
Office: United States
State Tower
90 State Street, Suite 700
Albany, NY 12207
United States

Toll Free: 866-997-4948
Tel: +1-518-618-1030
E: sales@marketresearchreports.biz


Orthopedic Soft Tissue Repair Market (Surgical Procedures - ACL/PCL Reconstruction, Meniscal Repair, Rotator Cuff Repair, Hip Arthroscopy, Biceps Tenodesis And Shoulder Labrum Repair) - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019

Orthopedic Soft Tissue Repair Market (Surgical Procedures - ACL/PCL Reconstruction, Meniscal Repair, Rotator Cuff Repair, Hip Arthroscopy, Biceps Tenodesis And Shoulder Labrum Repair) - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019

Orthopedic soft tissue repair is a branch of medicine that deals with the diagnosis, treatment, and prevention of injuries and illnesses resulting from sports, exercise, aging, soft tissue damage and recreational activities. Globally, increase in aging population is playing a major role in increasing the incidence of sports injuries resulting in increased demand for orthopedic soft tissue repair procedures. Aging is also an important factor, which diminishes body functions and movements which makes the body more prone to injuries, thereby driving growth in orthopedic soft tissue repair market.

Browse Full Report With TOC:
http://www.marketresearchreports.biz/analysis-details/orthopedic-soft-tissue-repair-and-sports-medicine-market-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019

ACL/PCL reconstruction is the largest practiced procedure in the orthopedic soft tissue repair market and it is expected to grow at a CAGR of about 8.3% during 2013 – 2019. Some of the other major procedures for orthopedic soft tissue repair are Meniscal Repair, Hip Arthroscopy, Rotator Cuff, Shoulder Labrum and Biceps Tenodesis Globally, majority of knee injury incidences are reported during sports activities. This is followed by shoulder and hip injuries. The report forecasts future potential of all these orthopedic soft tissue repair procedures and analyses drivers and opportunities, restraints and challenges, market trends, Porter’s forces, competitive landscape and company profiles of key players.

Aging is considered as one of the main factors which causes rise in orthopedic soft tissue injuries including knee injuries. In the segment of geographic analysis, the orthopedic soft tissue repair market report identifies and analyses market size and forecast of North America, Europe, Asia Pacific and Rest of the World (RoW). The North American region covers the scenario of the orthopedic soft tissue repair market in the U.S. The Europe region covers the scenario of the market in France, Germany and the U.K. Asia Pacific region highlights the market in India, China and Japan.  

Browse Full Report With TOC:
http://www.marketresearchreports.biz/sample/sample/185688

Table of Content

Chapter 1 Preface
1.1 Report Description
1.2 Research Methodology
1.2.1 Sources
1.2.1.1 Secondary Research
1.2.1.2 Primary Research
1.2.1.3 Assumptions

Chapter 2 Executive Summary

Chapter 3 Orthopedic Soft Tissue Repair– Industry Analysis
3.1 Market Introduction
3.2 Drivers
3.2.1 Aging population and increased obesity rate
3.2.2 Introduction of new medicine technologies
3.2.3 High incidence rate of orthopaedic soft tissue damage and sports injury
3.2.4 Increased healthcare expenditure
3.2.5 Lack of substitution for orthopaedic soft tissue repair surgery
3.3 Restraints
3.3.1 Lack of awareness among people regarding orthopedic soft tissue repair
3.3.2 Limited claim on surgeries by insurers
3.3.3 Rising cost of surgical procedures
3.3.4 Absence of health insurance in developing countries

To Get Download Full Report with TOC:
http://www.marketresearchreports.biz/analysis/185688

Chapter 4 Market Trends 23
4.1 Shifting of orthopedic devices from metallic to bioabsorbable (non-metallic) anchor
4.2 Geographic expansion of orthopedic soft tissue repair devices in developing countries
4.3 Robot-assisted surgery

Chapter 5 Porter’s Five Force Analysis
5.1 Porter’s five force analysis
5.1.1 Bargaining power of suppliers
5.1.2 Bargaining power of buyers
5.1.3 Threat from new entrants
5.1.4 Threat from substitutes
5.1.5 Intensity of rivalry

Chapter 6 Market segmentation based on surgical procedures
6.1 ACL/PCL Reconstruction Market
6.2 Meniscal Repair Market
6.3 Rotator Cuff Repair Market
6.4 Hip Arthroscopy Market
6.5 Biceps Tenodesis Market
6.6 Shoulder Labrum Repair Market

Contact US:  

Office: United States
State Tower
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
E: sales@marketresearchreports.biz

Seasonings And Spices Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019

Seasonings And Spices Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019

Increasing income levels resulting in increasing expenditure on food products, changing food habits of Asian consumers and changing demographics are the major growth drivers for the global seasonings and spices market. The seasonings and spices market is considered to be one of the most recession-proof markets since during uncertain economic conditions, consumers prefer in-house preparation and consumption rather than opting for the expensive choice of eating out or having ready-meals. However, when the economy is in good shape the situation is reverse. Online marketing campaigns offer expansion opportunity for seasonings and spices market. Seasonings and spices companies have started new online advertising campaigns that encourage consumers to create new recipes at home. Companies are adopting different methods for their campaign such as creating their own ‘Apps’ for product recipes, social media posts and contests, including ‘likes,’ ‘comments,’ ‘photo tags’ and ‘pins’ in social networking sites such as Facebook, Pinterest, Twitter and YouTube. Such campaigns help the companies in improved connectivity with consumers and thus help in establishing their brand identity in the seasonings and spices market.

Browse Full Report With TOC:
http://www.marketresearchreports.biz/analysis-details/seasoning-and-spices-market-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019

The report covers in-depth analysis seasonings and spices market, by product segment (Salt and Salt Substitutes, Pepper, Herbs, Spices and Others) for the period from 2008 to 2019. In addition, the current market dynamics including the drivers, restraints, trends and recent developments have been captured throughout the report. The seasonings and spices market for the major countries in each of the four regions, North America, Europe, Asia Pacific and Rest of the World includes historical and forecasted market sizes (2008-2019), in terms of volume and value. North America region covers the scenario in the U.S. Europe region covers the scenario of the U.K., Germany, Italy, Spain and France. Asia-Pacific region highlights the scenario in Australia, Japan, India and China. The report also covers the scenario in the Brazil seasonings and spices market.

The Competitive Landscape section of the seasonings and spices market report includes the market share of companies and the positioning of different countries based on per capita consumption and expected growth rate. Some of the major players in the seasonings and spices market are Everest Spices, MDH Spices, Catch, McCormick & Company, Nestle, Knorr and Kraft Foods. The company profiles in the seasonings and spices market report include attributes such as company overview, financial performance, and strategic developments.


Browse Full Report With TOC:
http://www.marketresearchreports.biz/analysis/181015

Table of Content

Chapter 1 Preface 11
1.1 Report description 11
1.2 Scope and definition 11
1.2.1 Product segments covered in the report 11
1.2.2 Regions covered in the report 11
1.3 Research methodology 11

Chapter 2 Executive Summary 13

Chapter 3 Seasonings and Spices - Market Overview 15
3.1 Introduction 15
3.2 Drivers 15
3.2.1 Globalization and changing demographics is expected to drive seasonings and spices demand 15
3.2.2 Consumers’ rising income levels expected to provide better growth prospects for the industry 16
3.2.3 Consumers’ changing food habits in Asian countries expected to escalate market growth 17
3.2.4 Medicinal benefits of spices is expected to drive the market 17
3.3 Restraints 18
3.3.1 Government policies resulting in rejection of imported spices may hamper market growth 18
3.3.2 Uncertain climatic conditions and inefficient logistics in spice producing countries impact the supply negatively 19
3.4 Opportunities 19
3.4.1 Increasing demand for organic seasonings and spices is expected to boost the market demand 19
3.4.2 Online marketing campaigns offer expansion opportunity for seasonings and spices market 20
3.5 Porter’s five forces analysis 21
3.5.1 Bargaining power of suppliers 21
3.5.2 Bargaining power of buyers 22
3.5.3 Threat of new entrants 22
3.5.4 Threat of substitutes 22
3.5.5 Intensity of rivalry 22

To Get Download Full Report with TOC:
http://www.marketresearchreports.biz/sample/sample/181015

Chapter 4 Seasonings and Spices – By Product Analysis 24
4.1 Salt and Salt Substitutes 26
4.2 Pepper 27
4.3 Herbs 29
4.4 Spices 30

Contact US:  

Office: United States
State Tower
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
E: sales@marketresearchreports.biz

Smoking Cessation And Nicotine De-Addiction Products Market (Nicotine Gums, Patches, Lozenges, Inhalers, Sprays, Sublingual Tablets, Zyban, Chantix/Champix, E-Cigarettes) - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019

Smoking Cessation And Nicotine De-Addiction Products Market (Nicotine Gums, Patches, Lozenges, Inhalers, Sprays, Sublingual Tablets, Zyban, Chantix/Champix, E-Cigarettes) - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019

Smoking cessation or nicotine de-addiction can be achieved by various modes such as nicotine replacement products, e-cigarettes, anti-depressants and nicotine receptor agonists such as Zyban (bupropion), and Chantix/Champix (varenicline). Smoking de-addiction is also possible with or without assistance of healthcare professionals. The smoking cessation products market has been extensively analyzed on the basis of factors such as the products popularly used, success rate, and geographical reach.

Browse Full Report With TOC:
http://www.marketresearchreports.biz/analysis-details/smoking-cessation-and-nicotine-de-addiction-products-market-nicotine-gums-patches-lozenges-inhalers-sprays-sublingual-tablets-zyban-chantixchampix-e-cigarettes-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019

This report studies the global smoking cessation and nicotine de-addiction products market from the perspective of various product types available in the market. These include nicotine replacement therapy (NRT) products, drug therapy and e-cigarettes. The NRT products market is broadly segmented into nicotine containing gums, transdermal patches, lozenges, sublingual tablets, sprays and nasal inhalers. The prominently used brands for smoking cessation are Zyban and Chantix/Champix which comprise the drug therapy segment of the market. Geographically, the market is analyzed for four major regions, namely North America, Europe, Asia Pacific and Rest of the World (RoW).

Each of the segments have been analyzed on the basis of their current and future market size for the period 2011 to 2019, in terms of revenue (USD million), considering 2011 and 2012 as the base years. The compounded annual growth rate (% CAGR) for each market segment has been provided for the forecast period 2013 to 2019 along with the estimations of market size.

Browse Full Report With TOC:
http://www.marketresearchreports.biz/sample/sample/192907

A competitive landscape, mapping all the market players and their respective shares in the smoking cessation and nicotine de-addiction products market for 2012 are provided in this report. Some of the major players profiled for NRT products include Johnson & Johnson, GSK, Pfizer, Takeda Pharmaceuticals Co. Ltd., Cipla, and Revolymer PLC. GSK and Pfizer lead the market for drug therapy while the key players profiled for e-cigarettes market include VMR products, and NJOY. Each of these smoking cessation and nicotine de-addiction products market players are profiled in the report considering parameters such as company overview, financial overview, business strategies, product portfolio and recent developments.

Table of Contents

Chapter 1 Introduction
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.3.1 Secondary Research
1.3.2 Primary Research
1.3.3 List of Abbreviations
1.3.4 Assumptions and Stipulations

Chapter 2 Executive Summary

Chapter 3 Global Smoking Cessation and Nicotine De-addiction Market Overview
3.1 Market Definition and Overview
3.1.1 Nicotine Consumption, Prevalence And Trends
3.1.2 Smoking Health Hazards
3.2 R&D Pipeline
3.3 Combination Therapy for Smoking Cessation/Nicotine De-addiction
3.4 Market Dynamics
3.4.1 Market Drivers
3.4.1.1 Rising Awareness about Smoking Health Hazards and Smoking Cessation Therapy
3.4.1.2 Government intervention for smoking de-addiction
3.4.1.3 Introduction of new products will expand the market
3.4.1.4 Reimbursement for smoking cessation therapy
3.4.2 Restraints
3.4.2.1 Low awareness about smoking cessation products in the developing economies
3.4.2.2 Legal obligations dragging growth of several smoking cessation product segments
3.4.3 Opportunities
3.4.3.1 Research and Development
3.4.3.2 Market Expansion
3.5 Porter’s Five Forces Analysis for the Global Smoking Cessation and Nicotine De-addiction Products Market
3.5.1 Bargaining Power Of Suppliers
3.5.2 Bargaining Power of Buyers
3.5.3 Threat from New Entrants
3.5.4 Threat from Substitutes
3.5.5 Competitive Rivalry
3.6 Market Attractiveness Analysis: Global Smoking Cessation and Nicotine De-addiction Products Market, by Geography

To Get Download Full Report with TOC:
http://www.marketresearchreports.biz/analysis/192907 

Chapter 4 Global Smoking Cessation and Nicotine De-addiction Products Market, by Product Type
4.1 Introduction
4.1.1 Global Smoking Cessation and Nicotine De-addiction Products Market, by Product Type, 2011 - 2019 (USD Million)
4.2 Nicotine Replacement Therapy Products
4.2.1 Global Nicotine Replacement Therapy Products Market Revenue, 2011 - 2019 (USD Million)
4.2.1 Nicotine Gums
4.2.1.1 Global Nicotine Gums Market Revenue, 2011 - 2019 (USD Million)
4.2.2 Nicotine Transdermal Patches
4.2.2.1 Global Nicotine Transdermal Patches Market Revenue, 2011 - 2019 (USD Million)
4.2.3 Nicotine Lozenges
4.2.3.1 Global Nicotine Lozenges Market Revenue, 2011 - 2019 (USD Million)
4.2.4 Nicotine Sprays
4.2.4.1 Global Nicotine Sprays Market Revenue, 2011 - 2019 (USD Million)
4.3 Nicotine Inhalers
4.3.1 Global Nicotine Inhalers Market Revenue, 2011 - 2019 (USD Million)
4.4 Nicotine Sublingual Tablets

Contact US:  

Office: United States
State Tower
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
E: sales@marketresearchreports.biz